Asthma/COPD drugs reflecting disease prevalence, patient adherence and persistence

References

• Doro P, Benko R, Kosik E et al. Utilization of oral antihyperglycemic drugs over a 7-year period (1998–2004) in a Hungarian population and adherence to drug therapy. Eur. J. Clin. Pharmacol.61(12), 893–897 (2005).
   PubMed Web of Science ®Google Scholar
• Larsen J, Andersen M, Kragstrup J, Gral LF. High persistence of statin use in a Danish population: compliance study 1993–1998. Br. J. Clin. Pharmacol.53(4), 375–378 (2002).
   PubMed Web of Science ®Google Scholar
• Dorais M, Blais L, Chabot I, LeLorier J. Treatment persistence with leucotriene receptor antagonists and inhaled corticosteroids. J. Asthma42(5), 385–393 (2005).
   PubMed Web of Science ®Google Scholar
• Catalan VS, Couture JA, LeLorier J. Predictors of persistence of use of the novel antidiabetic agent acarbose. Arch. Int. Med.161(8), 1106–1112 (2001).
   PubMed Web of Science ®Google Scholar
• Poluzzi E, Strahinja P, Vacceri A et al. Adherence to chronic cardiovascular therapies: persistence of the years and dose coverage. Br. J. Clin. Pharmacol.63(3), 346–355 (2007)
   PubMed Web of Science ®Google Scholar
• Bateman ED, Hurd SS, Barnes PJ et al. Global strategy for asthma management and prevention: GINA executive summary. Eur. Respir. J.31(1), 143–178 (2008).
   PubMed Web of Science ®Google Scholar
• Osborn M. Sex-related differences in health care utilization in asthma: what is the next step? Ann. Allerg. Asthma Immunol.96, 636–637 (2006).
   PubMedGoogle Scholar
• Gluck PA, Gluck JC. Asthma in women: special considerations. Ann. Allerg. Asthma Immunol.96(5), 635 (2006).
   PubMedGoogle Scholar
• Editorial A plea to abandon asthma as a disease concept. Lancet368(9537), 705 (2006).
   PubMed Web of Science ®Google Scholar
• Jack CIA, Lye M. Asthma in the elderly patient. Gerontology42(2), 61–68 (1996).
   PubMedGoogle Scholar
• Eder W, Ege MJ, von Mutius E. The asthma epidemic. N. Engl. J. Med.355(21), 2226–2235 (2006).
   PubMed Web of Science ®Google Scholar
• Peters SP, Ferguson G, Deniz Y, Reisner C. Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment. Resp. Med.100(7), 1139–1151 (2006).
   PubMed Web of Science ®Google Scholar
• Sin DD, Man J, Sharpe H et al. Pharmacological management to reduce exacerbations in adults with asthma. A systematic review and meta-analysis. JAMA292(3), 367–376 (2004).
   PubMed Web of Science ®Google Scholar
• O’Bryne P, Parameswaran K. Pharmacological management of mild or moderate persistent asthma. Lancet368(9537), 784–803 (2006).
   Google Scholar
• Rees J. Asthma control in adults. BMJ332(7544), 767–771 (2006).
   PubMedGoogle Scholar
• Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Resp. Crit. Care Med.176(6), 532–555 (2007).
   PubMed Web of Science ®Google Scholar
• Hasselgren M, Arne M, Lindahl A et al. Estimated prevalences of respiratory symptoms, asthma and chronic obstructive pulmonary disease related to detection rate in primary health care. J. Prim. Health Care (Scand.)19(1), 54–57 (2001).
   PubMed Web of Science ®Google Scholar
• Devereux G. ABC of chronic obstructive pulmonary disease. BMJ332(7550), 1142–1144 (2006).
   PubMed Web of Science ®Google Scholar
• Lundbäck B, Gulsvik A, Albers M et al. Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly. Eur. Resp. J.21(Suppl. 40), S3–S9 (2003).
   PubMedGoogle Scholar
• Lundbäck B, Lindberg A, Lindström M et al. Not 15 but 50% of smokers develop COPD – report from the obstructive lung disease in northern Sweden studies. Resp. Med.97(2), 115–122 (2003).
   PubMed Web of Science ®Google Scholar
• Rennard SI, Vestbo J. COPD: the dangerous underestimate of 15%. Lancet367(9518), 1216–1219 (2006).
   PubMed Web of Science ®Google Scholar
• Jansson S-A, Andersson F, Borg S et al. Cost of COPD in Sweden according to disease severity. Chest122(6), 1994–2002 (2002).
   PubMed Web of Science ®Google Scholar
• Mapel DW. Treatment implications on morbidity and mortality in COPD. Chest126(2 Suppl.), S150–S161 (2004).
   PubMedGoogle Scholar
• Sin DD, Man SFP. Corticosteroids and adrenoreceptor agonists: the compliments for combination therapy in chronic airways diseases. Eur. J. Pharmacol.533(1–3), 28–35 (2006).
   PubMed Web of Science ®Google Scholar
• Rennard SI, Higenbottam T. Exacerbation-free COPD: a goal too far? Proc. Am. Thorac. Soc.4(8), 583–585 (2007).
   PubMedGoogle Scholar
• Peytremann-Bridgevaux I, Staeger P, Bridgevaux PO et al. Effectiveness of chronic obstructive disease-management programs: systematic review and meta-analysis. Am. J. Med.121(5), 433–443 (2008).
   PubMedGoogle Scholar
• Celli BR. Update on the management of COPD. Chest133(6), 1451–1462 (2008).
   PubMed Web of Science ®Google Scholar
• Dai Negro R. Optimizing economic outcome in the management of COPD. Int. J. Chron. Obstruct. Dis.3, 1–10 (2008).
   PubMedGoogle Scholar
• Starkie HJ, Briggs AH, Chambers MG. Pharmacoeconomics in COPD: lessons for the future. Int. J. Chron. Obstruct. Dis.3(1), 71–88 (2008).
   PubMedGoogle Scholar
• Albert P, Calverley PM. Drugs (including oxygen) in severe COPD. Eur. Respir. J.31(5), 1114–1124 (2008).
   PubMed Web of Science ®Google Scholar
• Wettermark B, Hammar N, Fored CM et al. A new Swedish prescribed drug register – opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol. Drug Safety16(7), 726–735 (2007).
   PubMed Web of Science ®Google Scholar
• Montnemery P, Hansson L, Lanke J et al. Accuracy of a first diagnosis of asthma in primary health care. Fam. Pract.19(4), 365–368 (2002).
   PubMed Web of Science ®Google Scholar
• Marklund B, Tunsäter A, Bengtsson C. How often is the diagnosis bronchial asthma correct? Fam. Pract.16(2), 112–116 (1999).
   PubMed Web of Science ®Google Scholar
• Navaratnam P, Jayawant SS, Pedersen CA et al. Physician adherence to the national prescribing guidelines: evidence from national outpatient survey data in the United States. Ann. Allergy Asthma Immunol.100(3), 216–221 (2008).
   PubMed Web of Science ®Google Scholar
• Craig BM, Kraus CK, Chewning BA et al. Quality of care for older adults with chronic obstructive pulmonary disease and asthma based on comparisons to practice guidelines and smoking status. BMC Health Serv. Res.8, 144 (2008).
   PubMedGoogle Scholar
• Incalzi RA, Corsonello A, Pedone C et al. From Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines to current clinical practice: an overview of the pharmacological therapy to stable chronic obstructive pulmonary disorder. Drugs Aging23(5), 411–420 (2006).
   PubMedGoogle Scholar
• Vegni FE, Wilkinson P. Metodological issues in using drugs data in epidemiology. Ann. Ig.16(3), 479–485 (2004).
   PubMedGoogle Scholar
• Vegni FE, Wilkinson P. The role of drug use data in public health research. Ann. Ig.16(3), 487–495 (2004).
   PubMedGoogle Scholar
• Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J. Clin. Epidemiol.58(4), 323–337 (2005).
   PubMed Web of Science ®Google Scholar
• Hallas J. Drug utilization statistics for individual-level pharmacy dispensing data. Pharmacoepidemiol. Drug Safety14(7), 455–463 (2005).
   PubMed Web of Science ®Google Scholar
• Gaist D, Hallas J, Hansen NC, Gram LF. Are young adults with asthma treated sufficiently with inhaled steroids? A population-based study of prescription data from 1991 and 1994. Br. J. Clin. Pharmacol.41(4), 285–289 (1996).
   PubMedGoogle Scholar
• Pont LG, van der Werf GT, Denig P, Haaijer-Ruskamp FM. Identifying general practice patients with asthma and their exacerbation episodes from prescribing data. Eur. J. Clin. Pharmacol.57(11), 819–825 (2002).
   PubMed Web of Science ®Google Scholar
• Furu K, Skurtveit S, Langhammer A, Nafstad P. Use of anti-asthmatic medications as a proxy for prevalence of asthma in children and adolescents in Norway: a nationwide prescription database analysis. Eur. J. Clin. Pharmacol.63(7), 693–698 (2007).
   PubMed Web of Science ®Google Scholar
• Duarte-Ramos F, Cabrita J. Using a pharmacoepidemiological approach to estimate diabetes Type 2 prevalence in Portugal. Pharmacoepidemiol. Drug Safety15(4), 269–274 (2006).
   PubMedGoogle Scholar
• Wei L, Wang J, Thompson P, Wong S, Struthers AD, MacDonald TM. Adherence to statin treatment and readmission of patients after myocardial infarction: a 6 year follow up study. Heart88(3), 229–233 (2002).
   PubMed Web of Science ®Google Scholar
• Hedlin G, Janson C, Ställberg B. Astma och KOL (In Swedish). Läkemedelsboken ApoteketAB, Stockholm, Sweden 565–588 (2007/2008).
   Google Scholar
• Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch. Intern. Med.166, 1021–1026 (2006).
   PubMed Web of Science ®Google Scholar
• Naureckas ET, Dukic V, Bao X, Rathouz P. Short acting β-agonist prescription fills as a marker for asthma morbidity. Chest128(2), 602–608 (2005).
   PubMed Web of Science ®Google Scholar
• Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods validity, and applications. J. Clin. Epidemiol.50(1), 105–116 (1997).
   PubMed Web of Science ®Google Scholar
• Andersson K, Melander A, Svensson C et al. Repeat prescriptions – refill adherence in relation to patient and prescriber characteristics, reimbursement level and type of medication. Eur. J. Public Health15(6), 621–626 (2005).
   PubMedGoogle Scholar
• Krigsman K, Nilsson JLG, Ring L. Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions. Pharmacoepidemiol. Drug Saf.16(4), 441–448 (2007).
   PubMed Web of Science ®Google Scholar
• Guidelines for ATC classification and DDD assignment 2006. WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway (2006).
   Google Scholar
• Haupt D, Wettermark B, Nilsson JLG. Dispensed volumes of anti-asthmatic drugs related to the prevalence of asthma and COPD in Sweden. Pharmacoepidemiol. Drug Saf.17(5), 461–467 (2008).
   PubMedGoogle Scholar
• Hasselgren M. Epidemiological aspects of asthma in primary care. Dissertation number: 90. Faculty of Medicine, Uppsala University, Sweden (2005).
   Google Scholar
• Pallasaho P, Lundbäck B, Meren M et al. Prevalence and risk factors for chronic bronchitis in the capitals Helsinki, Stockholm and Tallinn. Resp. Med.96(10), 759–769 (2002).
   PubMed Web of Science ®Google Scholar
• Björnson E, Plaschke P, Norrman E et al. Symptoms related to asthma and chronic bronchitis in three areas of Sweden. Eur. Resp. J.7(12), 2146–2153 (1994).
   PubMedGoogle Scholar
• Lindström M, Jönsson E, Larsson K, Lundbäck B. Underdiagnosing of obstructive lung disease in northern Sweden. Int. J. Tuber. Lung Dis.6(1), 78–84 (2002).
   Google Scholar
• Nilsson JLG, Johansson H, Wennberg M. Large differences between prescribed and dispensed medicines could indicate undertreatment. Drug Inf. J.29(4), 1243–1246 (1995).
   Google Scholar
• World Health Organization. Adherence to long term therapies. Evidence for action. WHO Report, Geneva, Switzerland (2003).
   Google Scholar
• Stern L, Berman J, Lumry W et al. Medication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care data. Ann. Allerg. Asthma Immunol.97(3), 402–408 (2006).
   PubMed Web of Science ®Google Scholar
• Gillissen A. Patients’ adherence in asthma. J. Physiol. Pharmacol.58(Suppl. 5), 205–222 (2007).
   PubMed Web of Science ®Google Scholar
• Simpson SH, Eurich DT, Majumdar SR et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ333(7557), 15–18 (2006).
   PubMed Web of Science ®Google Scholar
• Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA297(2), 177–186 (2007).
   PubMed Web of Science ®Google Scholar
• Krigsman K, Moen J, Nilsson JLG, Ring L. Refill adherence by elderly for asthma/COPD drugs dispensed over a ten-year period. J. Clin. Pharm. Ther.32(6), 603–611 (2007).
   PubMed Web of Science ®Google Scholar
• Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann. Pharmacother.38(2), 303–312 (2004).
   PubMed Web of Science ®Google Scholar
• Mortensen PB. Register-based research in Denmark. Nor. J. Epidemiol.14(1), 121–124 (2004).
   Google Scholar
• Otterblad Olausson PO, Spetz CL, Rosén M. Stor användning av registerdata i svensk forskning – en nordisk konkurrensfördel (In Swedish). Nor. J. Epidemiol.14(1), 125–128 (2004).
   Google Scholar
• Gissler M, Haukka J. Finnish health and social welfare registers in epidemiological research. Nor. J. Epidemiol.14(1), 113–120 (2004).
   Google Scholar
• Cappelen I, Lyshol H. An overview of the health registers in Norway. Nor. J. Epidemiol.14(1), 33–38 (2004).
   PubMedGoogle Scholar
• Cramer JA, Roy A, Burell A et al. Medication compliance and persistence: terminology and definitions. Value Health11(1), 44–47 (2008).
   PubMed Web of Science ®Google Scholar
• Lynd LD, Guh DP, Paré PD, Anis AH. Patterns of inhaled asthma medication use. A 3-year longitudinal analysis of prescription claims data from British Columbia, Canada. Chest122(6), 1973–1981 (2002).
   PubMedGoogle Scholar
• Haupt D, Krigsman K, Nilsson JLG. Medication persistence among patients with asthma/COPD drugs. Pharm. World Sci.30(5), 509–514 (2008).
   PubMed Web of Science ®Google Scholar
• Haupt D, Nilsson JLG. Defined daily doses (DDD) related to prescribed daily doses (PDD) for asthma/COPD drugs in Sweden. WHO Drug Info.20(1), 261–264 (2006).
   Google Scholar
• Nolte H, Nepper-Christenese S, Backer V. Unawareness and undertreatment of asthma and allergic rhinitis in a general population. Resp. Med.100(2), 354–362 (2006).
   PubMed Web of Science ®Google Scholar
• Enright PL, McClelland RL, Newman AB, Gottlieb DJ, Lebowitz MD. Underdiagnosis and undertreatment of asthma in the elderly. Chest116(3), 603–613 (1999).
   PubMed Web of Science ®Google Scholar
• Larsson L, Boetius G, Uddenfeldt M. Differences in utilization of asthma drugs between two neighbouring Swedish provinces: relation to prevalence of obstructive airway disease. Thorax49(1), 41–49 (1994).
   PubMed Web of Science ®Google Scholar